Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations

Although many approaches have been developed for the treatment of hepatocellular carcinoma (HCC) that has both high incidence and high mortality especially in Asian countries, the prognosis of HCC patients is still dismal. Immunotherapy, particularly immune checkpoint inhibitors show encouraging eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qi, Chen, Yiwen, Bai, Xueli, Liang, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593704/
https://www.ncbi.nlm.nih.gov/pubmed/33178615
http://dx.doi.org/10.3389/fonc.2020.590058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593704/
https://www.ncbi.nlm.nih.gov/pubmed/33178615
http://dx.doi.org/10.3389/fonc.2020.590058

Ejemplares similares